What’s New
-
Materials from the HTAsiaLink 2026 (Taipei) session have been posted
-
New C2H Report: Tirzepatide (Zepbound)
-
New C2H Report: Donanemab (Kisunla)
Materials from the HTAsiaLink 2026 (Taipei) session have been posted
New C2H Report: Tirzepatide (Zepbound)
New C2H Report: Donanemab (Kisunla)